Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
01/18/2007 | US20070015816 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
01/18/2007 | US20070015762 NPY Y5 antagonist |
01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
01/18/2007 | DE102005032836A1 Verfahren zur Herstellung von Onium-Alkylsulfonaten A process for the preparation of onium alkylsulfonates |
01/18/2007 | DE102005032307A1 Oligomere freier Fettsäuren und diese enthaltende Arzneimittel Oligomers of free fatty acids and pharmaceutical compositions containing them |
01/17/2007 | EP1743884A1 Progrugs to d-prolines |
01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
01/17/2007 | EP1742911A1 3,4-disubstituted maleimides for use as vascular damaging agents |
01/17/2007 | EP1742910A1 Process for forming amorphous atorvastatin calcium |
01/17/2007 | EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof |
01/17/2007 | EP1742908A1 Non-nucleoside reverse transcriptase inhibitors |
01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
01/17/2007 | EP1742905A2 Process of making alfa-aminooxyketone/ alfa-aminooxyaldehyde and alfa-hydroxyketone/ alfa-hydroxyaldehyde compounds and a process of making reaction products from cyclic alfa, beta-unsaturated ketone substrates and nitroso substrates |
01/17/2007 | CN1898234A Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
01/17/2007 | CN1898213A Heteroaroyl-substituted phenylalanineamides with herbicidal action |
01/17/2007 | CN1897946A 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
01/17/2007 | CN1896059A Process for separating imide compounds |
01/17/2007 | CN1896058A Maleimide derivative and its preparation |
01/17/2007 | CN1896057A Pentazane derivative intermediate, its preparation and use |
01/17/2007 | CN1295215C New Optical active derivative of flavo acidamide, its preparation method and its medicinal composition and use |
01/16/2007 | US7164031 Liquid phase reacting of gamma-butyrolactone with ammonia and water; heating, pressurization |
01/16/2007 | US7164027 Aralkyl ester soft drugs |
01/16/2007 | US7163937 Cyclic derivatives as modulators of chemokine receptor activity |
01/16/2007 | CA2257234C Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
01/16/2007 | CA2221397C Process for the production of aromatic halogen-amino compounds |
01/11/2007 | WO2007005503A1 Histamine h3 receptor agents, preparation and therapeutic uses |
01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
01/11/2007 | WO2007003963A1 Zofenopril calcium in polymorph form c |
01/11/2007 | WO2006117669B1 Amide resorcinol compounds |
01/11/2007 | WO2005123742A3 A new route to formyl-porphyrins |
01/11/2007 | US20070010569 4-Methyl-5-(2-oxo-1,2-dihydroindol-3- ylidenemethyl)-1H-pyrrole-2- carboxylic acid; cancer |
01/11/2007 | US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
01/11/2007 | US20070010509 Cycloamine ccr5 receptor antagonists |
01/11/2007 | US20070006396 Composition for dyeing keratin fibers with a cationic direct dye and a thickening polymer |
01/11/2007 | DE102005025989A1 Carboxamide Carboxamides |
01/11/2007 | CA2614193A1 Zofenopril calcium in polymorph form c |
01/11/2007 | CA2613192A1 Histamine h3 receptor agents, preparation and therapeutic uses |
01/11/2007 | CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
01/10/2007 | EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors |
01/10/2007 | EP1740573A1 Amides as bace inhibitors |
01/10/2007 | EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives |
01/10/2007 | EP1740553A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors |
01/10/2007 | EP1740540A1 Phenyl acetamides |
01/10/2007 | EP1740537A2 A process for the preparation of 2,2-disubstituted pyrroles |
01/10/2007 | EP1740522A2 Bisphenyl compounds useful as vitamin d sb 3 /sb receptor agonists |
01/10/2007 | EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
01/10/2007 | EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase |
01/10/2007 | CN1894219A Optically active carboxamids and use thereof to combat undersirable microorganisms |
01/10/2007 | CN1894211A Preparation of 4,5-dialkyl-3-acyl-pyrrole-2-carboxylic acid derivatives by fischer-fink type synthesis and subsequent acylation |
01/10/2007 | CN1894210A Prolinylarylacetamides |
01/10/2007 | CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
01/10/2007 | CN1893977A Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient. |
01/10/2007 | CN1891690A Ionization modifier for mass spectrometry |
01/10/2007 | CN1891689A Aliphatic nitrogen - containing 5 - membered ring compound |
01/10/2007 | CN1891688A Arylpyrrole N-oxalate ester derivatives, and their preparation and use |
01/10/2007 | CN1891687A Inflammatory factor receptor antagonistic active compound from microbe and its use |
01/10/2007 | CN1294121C Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage |
01/10/2007 | CN1294120C Pyrrolidinyl metalloprotease inhibitor and its application |
01/09/2007 | US7161012 Processes for preparing amorphous atorvastatin hemi-calcium |
01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
01/09/2007 | US7160914 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer |
01/09/2007 | US7160910 Anti-sickling agents |
01/09/2007 | US7160907 Pleuromutilin derivatives |
01/09/2007 | US7160905 Hydroxyethylene compounds with Asp2 inhibitory activity |
01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
01/09/2007 | US7160902 Amide derivatives and methods of their use |
01/09/2007 | US7160887 Aromatic amine derivatives, their production and use |
01/09/2007 | US7160886 For therapy and prophylaxis of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
01/09/2007 | US7160877 Aliphatic nitrogen-containing 5-membered ring compound |
01/09/2007 | US7160874 Phenylalanine derivatives |
01/04/2007 | WO2007002842A2 Substituted n-cinnamyl benzamides |
01/04/2007 | WO2007000641A2 Prostaglandin derivatives |
01/04/2007 | WO2007000505A2 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics |
01/04/2007 | WO2006047479A3 C-fms kinase inhibitors |
01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
01/04/2007 | US20070004726 4-[2-(3-tert-Butyl-4-diethylaminophenyl)-2-hydroxyiminoethoxy]benzoic acid; modulates nuclear retinoic acid receptors; suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or into cosmetic compositions |
01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
01/04/2007 | CA2613748A1 Prostaglandin derivatives |
01/04/2007 | CA2610805A1 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics |
01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
01/03/2007 | EP1739080A1 Ionization Modifier for Mass Spectrometry |
01/03/2007 | EP1737819A1 Amino acid and peptide conjugates of arylalkylic acids for cosmetic use |
01/03/2007 | EP1737818A2 Methods for the preparation of stereoisomerically enriched amines |
01/03/2007 | EP1737815A1 Thio-substituted biaryl-methanesulfinyl derivatives |
01/03/2007 | EP1737812A1 Methods of amination |
01/03/2007 | EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
01/03/2007 | CN1890212A Methods of preparing compounds useful as protease inhibitors |
01/03/2007 | CN1887828A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst |
01/03/2007 | CN1293073C Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands |
01/03/2007 | CN1293058C O-cyclopropyl-carboxanilides and their use as fungicides |
01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
01/03/2007 | CN1292744C Carboxylic acid derivs. that inhibit binding of integrins to their receptors |
01/02/2007 | US7157588 Based on an N-substituted pyrrolidinone having a pendant ammonium cation that is separated from the pyrrolidone ring by a variable length alkyl spacer; use as solvents, catalysts; can be readily prepared from levulinic acid or derivatives obtained from the hydrolysis of inexpensive biomass feedstock |
01/02/2007 | US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
01/02/2007 | US7157458 Bifunctional energy-reversible acyl-compositions |